Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19

Blood myeloid cells are known to be dysregulated in coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2. It is unknown whether the innate myeloid response differs with disease severity and whether markers of innate immunity discriminate high-risk patients. Thus, we performed high-dimensional f...

Descripción completa

Detalles Bibliográficos
Autores principales: Silvin, Aymeric, Chapuis, Nicolas, Dunsmore, Garett, Goubet, Anne-Gaëlle, Dubuisson, Agathe, Derosa, Lisa, Almire, Carole, Hénon, Clémence, Kosmider, Olivier, Droin, Nathalie, Rameau, Philippe, Catelain, Cyril, Alfaro, Alexia, Dussiau, Charles, Friedrich, Chloé, Sourdeau, Elise, Marin, Nathalie, Szwebel, Tali-Anne, Cantin, Delphine, Mouthon, Luc, Borderie, Didier, Deloger, Marc, Bredel, Delphine, Mouraud, Severine, Drubay, Damien, Andrieu, Muriel, Lhonneur, Anne-Sophie, Saada, Véronique, Stoclin, Annabelle, Willekens, Christophe, Pommeret, Fanny, Griscelli, Frank, Ng, Lai Guan, Zhang, Zheng, Bost, Pierre, Amit, Ido, Barlesi, Fabrice, Marabelle, Aurélien, Pène, Frédéric, Gachot, Bertrand, André, Fabrice, Zitvogel, Laurence, Ginhoux, Florent, Fontenay, Michaela, Solary, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405878/
https://www.ncbi.nlm.nih.gov/pubmed/32810439
http://dx.doi.org/10.1016/j.cell.2020.08.002

Ejemplares similares

Ejemplares similares